Clinical trial of CV 9202 in combination with chemo-radiation therapy in patients with unresectable stage III non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Sep 2014
At a glance
- Drugs CV 9202 (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 24 Sep 2014 New trial record